MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare SLU-PP-332 listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1, 5, 10. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 5 mg | 1 vial | $80.00 | $16.00 | 1 | Compare |
| 10 mg | 1 vial | $79.99 | $8.00 | 2 | Compare |

122 products · 249 listings

153 products · 275 listings

23 products · 62 listings

31 products · 35 listings

38 products · 72 listings
4 listings from direct supplier captures and 4 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
SLU-PP-332 is a synthetic small molecule rather than a peptide, developed in Thomas Burris's medicinal chemistry laboratory at Saint Louis University as the first usable agonist of all three estrogen-related receptors. Because those receptors sit downstream of PGC-1 alpha and control mitochondrial biogenesis and fatty acid oxidation, the compound switches on much of the gene programme that aerobic training switches on, which is why it is described as an exercise mimetic. Every published study is in mice or cell lines: no human trial has been registered, there is no FDA approval or investigational application, and the compound does not appear on the FDA list of bulk substances that pharmacies may compound. It reached the research-chemical market after a 2023 conference presentation and is sold as oral tablets, capsules and occasional injectable preparations, despite the originating laboratory reporting that the parent compound lacks oral bioavailability.
Important context about current evidence and why no dosing guide is presented
How SLU-PP-332 is thought to mimic parts of the exercise response
Findings from obesity, glucose control, and fat metabolism models
Why SLU-PP-332 is often described as an exercise mimetic
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.